Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes.

Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy. Trials (2012) 0.80

Prevention and management of post prostatectomy erectile dysfunction. Transl Androl Urol (2015) 0.78

Advances in Robotic-Assisted Radical Prostatectomy over Time. Prostate Cancer (2013) 0.76

Words of wisdom. Re: Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Eur Urol (2012) 0.75

Nerve-sparing techniques and results in robot-assisted radical prostatectomy. Investig Clin Urol (2016) 0.75

Re: stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. J Urol (2011) 0.75

Erectile dysfunction in robotic radical prostatectomy: Outcomes and management. Indian J Urol (2014) 0.75

Effect of minimizing tension during robotic-assisted laparoscopic radical prostatectomy on urinary function recovery. World J Urol (2012) 0.75

A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med (2009) 25.01

An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet (2008) 14.07

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61

Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA (2009) 7.25

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology (2012) 6.35

Marital status and survival in patients with cancer. J Clin Oncol (2013) 5.82

Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol (2011) 4.60

The intensity and variation of surgical care at the end of life: a retrospective cohort study. Lancet (2011) 4.44

Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23

Simulation-based trial of surgical-crisis checklists. N Engl J Med (2013) 4.14

The reliability of medical record review for estimating adverse event rates. Ann Intern Med (2002) 4.02

Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol (2011) 3.96

Global operating theatre distribution and pulse oximetry supply: an estimation from reported data. Lancet (2010) 3.84

The digital divide in adoption and use of a personal health record. Arch Intern Med (2011) 3.69

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62

Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr (2004) 3.55

Changes in medical errors after implementation of a handoff program. N Engl J Med (2014) 3.50

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med (2004) 3.50

Crisis checklists for the operating room: development and pilot testing. J Am Coll Surg (2011) 3.19

Patterns of communication breakdowns resulting in injury to surgical patients. J Am Coll Surg (2007) 3.09

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology (2013) 2.99

Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J Urol (2012) 2.94

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol (2005) 2.85

Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J Urol (2012) 2.79

Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy. J Urol (2010) 2.77

Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol (2004) 2.68

Economic costs of overactive bladder in the United States. Urology (2009) 2.68

Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys (2007) 2.55

Rates of medical errors and preventable adverse events among hospitalized children following implementation of a resident handoff bundle. JAMA (2013) 2.52

Choice reaction time performance correlates with diffusion anisotropy in white matter pathways supporting visuospatial attention. Proc Natl Acad Sci U S A (2005) 2.51

Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39

Influence of surgeon and hospital volume on radical prostatectomy costs. J Urol (2012) 2.37

Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology (2010) 2.31

Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Urology (2011) 2.24

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord (2006) 2.23

Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol (2012) 2.22

Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology (2013) 2.16

Changes in safety attitude and relationship to decreased postoperative morbidity and mortality following implementation of a checklist-based surgical safety intervention. BMJ Qual Saf (2011) 2.16

Risks of complications by attending physicians after performing nighttime procedures. JAMA (2009) 2.16

Effect of a 19-item surgical safety checklist during urgent operations in a global patient population. Ann Surg (2010) 2.14

Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care (2014) 2.14

Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int (2013) 2.12

The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med (2004) 2.11

Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria. Int J Urol (2014) 2.08

Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy. J Urol (2011) 2.05

Preoperative electrocardiograms: patient factors predictive of abnormalities. Anesthesiology (2009) 2.05

Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology (2013) 2.04

Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol (2010) 2.00

Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol (2011) 1.99

Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol (2012) 1.86

Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol (2012) 1.86

Utilization and expense of adjuvant cancer therapies following radical prostatectomy. Cancer (2011) 1.85

Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy. Urology (2010) 1.83

Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg (2009) 1.81

Genome size is a strong predictor of cell size and stomatal density in angiosperms. New Phytol (2008) 1.80

Lack of insurance negatively affects trauma mortality in US children. J Pediatr Surg (2009) 1.79

Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. J Urol (2012) 1.78

Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol (2002) 1.78

Association between a DASH-like diet and mortality in adults with hypertension: findings from a population-based follow-up study. Am J Hypertens (2009) 1.76

Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Eur Urol (2011) 1.76

Surgical outcome measurement for a global patient population: validation of the Surgical Apgar Score in 8 countries. Surgery (2011) 1.74

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol (2014) 1.74

Logistic regression with incomplete covariate data in complex survey sampling: application of reweighted estimating equations. Epidemiology (2009) 1.73

Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int (2013) 1.73

A simple method of determining confidence intervals for population attributable risk from complex surveys. Stat Med (2007) 1.73

Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res (2010) 1.71

Physicians' needs in coping with emotional stressors: the case for peer support. Arch Surg (2011) 1.66

Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg (2007) 1.66

Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism. Eur Urol (2012) 1.65

Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr (2012) 1.64